Skip to content
PubMed This is a summary of 54 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 54 referenced papers

Top Authors

Carsten Alexander Wagner
University of Zurich
Nati Hernando
University of Zurich
Angela Williams
Kyowa Kirin International (United Kingdom)
Karl P. Schlingmann
University Hospital Münster
Martin Konrad
University Hospital Münster
Justine Bacchetta
Lyon 1 Université
Dieter Haffner
Medizinische Hochschule Hannover
Detlef Böckenhauer
Great Ormond Street Hospital

Top Institutions

Ranked by publications Top 10 institutions
04

Kyowa Kirin International (United Kingdom)

Galashiels, United Kingdom

21 papers
06

Charité - Universitätsmedizin Berlin

Berlin, Germany

18 papers
09

Santa Lucía University General Hospital

Cartagena, Spain

6 papers

References

References (54)
  1. 1

    Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia.

    Schlingmann KP, Ruminska J, Kaufmann M, et al.

    Journal of the American Society of Nephrology : JASN 2016; (27(2)):604-14 doi:10.1681/ASN.2014101025.

    PMID: 26047794
  2. 2

    Ambulatory care after acute kidney injury: an opportunity to improve patient outcomes.

    Silver SA, Goldstein SL, Harel Z, et al.

    Canadian journal of kidney health and disease 2015; (2()):36 doi:10.1186/s40697-015-0071-8.

    PMID: 26445676
  3. 3

    Cystinosis: a review.

    Elmonem MA, Veys KR, Soliman NA, et al.

    Orphanet journal of rare diseases 2016; (11()):47 doi:10.1186/s13023-016-0426-y.

    PMID: 27102039
  4. 4

    Loss of function of NaPiIIa causes nephrocalcinosis and possibly kidney insufficiency.

    Dinour D, Davidovits M, Ganon L, et al.

    Pediatric nephrology (Berlin, Germany) 2016; (31(12)):2289-2297 doi:10.1007/s00467-016-3443-0.

    PMID: 27378183
  5. 5

    Late-onset hereditary hypophosphatemic rickets with hypercalciuria (HHRH) due to mutation of SLC34A3/NPT2c.

    Dhir G, Li D, Hakonarson H, Levine MA

    Bone 2017; (97()):15-19 doi:10.1016/j.bone.2016.12.001.

    PMID: 27939817
  6. 6

    Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH cases.

    Pronicka E, Ciara E, Halat P, et al.

    Journal of applied genetics 2017; (58(3)):349-353 doi:10.1007/s13353-017-0397-2.

    PMID: 28470390
  7. 7

    Hypercalcemic Disorders in Children.

    Stokes VJ, Nielsen MF, Hannan FM, Thakker RV

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2017; (32(11)):2157-2170 doi:10.1002/jbmr.3296.

    PMID: 28914984
  8. 8

    Clinical Heterogeneity and Phenotypic Expansion of NaPi-IIa-Associated Disease.

    Demir K, Yildiz M, Bahat H, et al.

    The Journal of clinical endocrinology and metabolism 2017; (102(12)):4604-4614 doi:10.1210/jc.2017-01592.

    PMID: 29029121
  9. 9

    Evidence for a role of PDZ domain-containing proteins to mediate hypophosphatemia in calcium stone formers.

    Bergsland KJ, Coe FL, Parks JH, et al.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2018; (33(5)):759-770 doi:10.1093/ndt/gfx284.

    PMID: 29126251
  10. 10

    Clinical, biochemical, and pathophysiological analysis of SLC34A1 mutations.

    Fearn A, Allison B, Rice SJ, et al.

    Physiological reports 2018; (6(12)):e13715 doi:10.14814/phy2.13715.

    PMID: 29924459
  11. 11

    Prenatal hyperechogenic kidneys in three cases of infantile hypercalcemia associated with SLC34A1 mutations.

    Hureaux M, Molin A, Jay N, et al.

    Pediatric nephrology (Berlin, Germany) 2018; (33(10)):1723-1729 doi:10.1007/s00467-018-3998-z.

    PMID: 29959532
  12. 12

    Hypocalcaemic and hypophosphatemic rickets.

    Lambert AS, Linglart A

    Best practice & research. Clinical endocrinology & metabolism 2018; (32(4)):455-476 doi:10.1016/j.beem.2018.05.009.

    PMID: 30086869
  13. 13

    Clinical aspects of the phosphate transporters NaPi-IIa and NaPi-IIb: mutations and disease associations.

    Lederer E, Wagner CA

    Pflugers Archiv : European journal of physiology 2019; (471(1)):137-148 doi:10.1007/s00424-018-2246-5.

    PMID: 30542787
  14. 14

    Emotional experience in parents of children with Zellweger spectrum disorders: A qualitative study.

    Bose M, Mahadevan M, Schules DR, et al.

    Molecular genetics and metabolism reports 2019; (19()):100459 doi:10.1016/j.ymgmr.2019.100459.

    PMID: 30815361
  15. 15

    Infantile hypercalcemia with novel compound heterozygous mutation in SLC34A1 encoding renal sodium-phosphate cotransporter 2a: a case report.

    Kang SJ, Lee R, Kim HS

    Annals of pediatric endocrinology & metabolism 2019; (24(1)):64-67 doi:10.6065/apem.2019.24.1.64.

    PMID: 30943683
  16. 16

    Primary Care Physicians' Perceived Barriers to Nephrology Referral and Co-management of Patients with CKD: a Qualitative Study.

    Greer RC, Liu Y, Cavanaugh K, et al.

    Journal of general internal medicine 2019; (34(7)):1228-1235 doi:10.1007/s11606-019-04975-y.

    PMID: 30993634
  17. 17

    Proximal renal tubular acidosis with and without Fanconi syndrome.

    Kashoor I, Batlle D

    Kidney research and clinical practice 2019; (38(3)):267-281 doi:10.23876/j.krcp.19.056.

    PMID: 31474092
  18. 18

    Multicenter study of the clinical features and mutation gene spectrum of Chinese children with Dent disease.

    Ye Q, Shen Q, Rao J, et al.

    Clinical genetics 2020; (97(3)):407-417 doi:10.1111/cge.13663.

    PMID: 31674016
  19. 19

    Exploring the burden of X-linked hypophosphatemia: a European multi-country qualitative study.

    Lo SH, Lachmann R, Williams A, et al.

    Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2020; (29(7)):1883-1893 doi:10.1007/s11136-020-02465-x.

    PMID: 32162120
  20. 20

    Hypophosphataemic Rickets: Similar Phenotype of Different Diseases.

    de la Cerda-Ojeda F, González-Rodríguez JD, Madariaga L, et al.

    Advances in therapy 2020; (37(Suppl 2)):80-88 doi:10.1007/s12325-019-01182-3.

    PMID: 32236875
  21. 21

    Idiopathic infantile hypercalcemia: mutations in SLC34A1 and CYP24A1 in two siblings and fathers.

    Güven A, Konrad M, Schlingmann KP

    Journal of pediatric endocrinology & metabolism : JPEM 2020; (33(10)):1353-1358.

    PMID: 32866123
  22. 22

    Novel Fanconi renotubular syndromes provide insights in proximal tubule pathophysiology.

    Lemaire M

    American journal of physiology. Renal physiology 2021; (320(2)):F145-F160 doi:10.1152/ajprenal.00214.2020.

    PMID: 33283647
  23. 23

    Plasma intact fibroblast growth factor 23 level is a useful tool for diagnostic approach of renal hypophosphatemia.

    Giralt M, Chocron S, Ferrer R, Ariceta G

    Pediatric nephrology (Berlin, Germany) 2021; (36(4)):1025-1028 doi:10.1007/s00467-020-04906-8.

    PMID: 33492457
  24. 24

    Experience with the targeted next-generation sequencing in the diagnosis of hereditary hypophosphatemic rickets.

    Turan I, Erdem S, Kotan LD, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2021; (34(5)):639-648 doi:10.1515/jpem-2020-0624.

    PMID: 33852231
  25. 25

    Mild Idiopathic Infantile Hypercalcemia-Part 2: A Longitudinal Observational Study.

    Lenherr-Taube N, Furman M, Assor E, et al.

    The Journal of clinical endocrinology and metabolism 2021; (106(10)):2938-2948 doi:10.1210/clinem/dgab432.

    PMID: 34139759
  26. 26

    Patient-Reported Complications, Symptoms, and Experiences of Living With X-Linked Hypophosphatemia Across the Life-Course.

    Cheung M, Rylands AJ, Williams A, et al.

    Journal of the Endocrine Society 2021; (5(8)):bvab070 doi:10.1210/jendso/bvab070.

    PMID: 34258488
  27. 27

    X-Linked Hypophosphatemic Rickets: Multisystemic Disorder in Children Requiring Multidisciplinary Management.

    Baroncelli GI, Mora S

    Frontiers in endocrinology 2021; (12()):688309 doi:10.3389/fendo.2021.688309.

    PMID: 34421819
  28. 28

    Fibroblast growth factor 23 leads to endolysosomal routing of the renal phosphate cotransporters NaPi-IIa and NaPi-IIc in vivo.

    Küng CJ, Haykir B, Schnitzbauer U, et al.

    American journal of physiology. Renal physiology 2021; (321(6)):F785-F798 doi:10.1152/ajprenal.00250.2021.

    PMID: 34719948
  29. 29

    Childhood Hypercalciuric Hypercalcemia With Elevated Vitamin D and Suppressed Parathyroid Hormone: Long-Term Follow Up.

    Gurevich E, Levi S, Borovitz Y, et al.

    Frontiers in pediatrics 2021; (9()):752312 doi:10.3389/fped.2021.752312.

    PMID: 34858904
  30. 30

    The Lived Experience of Parents' Receiving the Diagnosis of CDKL5 Deficiency Disorder for Their Child.

    Demarest S, Marsh R, Treat L, et al.

    Journal of child neurology 2022; (37(6)):451-460 doi:10.1177/08830738221076285.

    PMID: 35196159
  31. 31

    How the diagnosis and the management of genetic renal phosphate leak impact the life of kidney stone formers?

    Tostivint IN, Araman RG, Castiglione V, et al.

    Urolithiasis 2022; (50(3)):319-331 doi:10.1007/s00240-022-01316-3.

    PMID: 35224662
  32. 32

    Rickets guidance: part II-management.

    Haffner D, Leifheit-Nestler M, Grund A, Schnabel D

    Pediatric nephrology (Berlin, Germany) 2022; (37(10)):2289-2302 doi:10.1007/s00467-022-05505-5.

    PMID: 35352187
  33. 33

    Clinical Spectrum of Hereditary Hypophosphatemic Rickets With Hypercalciuria (HHRH).

    Stürznickel J, Heider F, Delsmann A, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2022; (37(8)):1580-1591 doi:10.1002/jbmr.4630.

    PMID: 35689455
  34. 34

    Metabolic and Genetic Evaluation in Children with Nephrolithiasis.

    Mandal A, Khandelwal P, Geetha TS, et al.

    Indian journal of pediatrics 2022; (89(12)):1243-1250 doi:10.1007/s12098-022-04234-9.

    PMID: 35819704
  35. 35

    Inherited Fanconi syndrome.

    Albuquerque ALB, Dos Santos Borges R, Conegundes AF, et al.

    World journal of pediatrics : WJP 2023; (19(7)):619-634 doi:10.1007/s12519-023-00685-y.

    PMID: 36729281
  36. 36

    Consensus recommendations on organization of care for individuals with Phelan-McDermid syndrome.

    van Eeghen AM, Stemkens D, Fernández-Fructuoso JR, et al.

    European journal of medical genetics 2023; (66(7)):104747 doi:10.1016/j.ejmg.2023.104747.

    PMID: 37003574
  37. 37

    Asia-Pacific Consensus Recommendations on X-Linked Hypophosphatemia: Diagnosis, Multidisciplinary Management, and Transition From Pediatric to Adult Care.

    Munns CF, Yoo HW, Jalaludin MY, et al.

    JBMR plus 2023; (7(6)):e10744 doi:10.1002/jbm4.10744.

    PMID: 37283655
  38. 38

    Genu Valgum, Fractures, and Renal Stones in a 10-year-old Girl.

    Christensen S, Loomba LA

    JCEM case reports 2023; (1(1)):luac022 doi:10.1210/jcemcr/luac022.

    PMID: 37908277
  39. 39

    Inherited non-FGF23-mediated phosphaturic disorders: A kidney-centric review.

    Walker E, Hayes W, Bockenhauer D

    Best practice & research. Clinical endocrinology & metabolism 2024; (38(2)):101843 doi:10.1016/j.beem.2023.101843.

    PMID: 38042745
  40. 40

    A Novel Heterozygous Mutation c.1627G>T (p.Gly543Cys) in the SLC34A1 Gene in a Male Patient with Recurrent Nephrolithiasis and Early Onset Osteopenia: A Case Report.

    Giusti F, Marini F, Al-Alwani H, et al.

    International journal of molecular sciences 2023; (24(24)) doi:10.3390/ijms242417289.

    PMID: 38139117
  41. 41

    Inherited Fanconi renotubular syndromes: unveiling the intricacies of hypophosphatemic rickets/osteomalacia.

    Ragate DC, Memon SS, Karlekar M, et al.

    Journal of bone and mineral metabolism 2024; (42(2)):155-165 doi:10.1007/s00774-023-01490-3.

    PMID: 38310177
  42. 42

    Antenatal presentation and early postnatal treatment of infantile hypercalcemia type 2.

    Verjans M, Hindryckx A, Rosier K, et al.

    Pediatric nephrology (Berlin, Germany) 2024; (39(10)):2911-2913 doi:10.1007/s00467-024-06403-8.

    PMID: 38753084
  43. 43

    Presentation and outcome in carriers of pathogenic variants in SLC34A1 and SLC34A3 encoding sodium-phosphate transporter NPT 2a and 2c.

    Brunkhorst M, Brunkhorst L, Martens H, et al.

    Kidney international 2025; (107(1)):116-129 doi:10.1016/j.kint.2024.08.035.

    PMID: 39461557
  44. 44

    Etiology, clinical characteristics, genetic profile, and outcomes of children with refractory rickets at a referral center in India: a cohort study.

    Mathew V, Deepthi B, Krishnasamy S, et al.

    Pediatric nephrology (Berlin, Germany) 2025; (40(6)):1915-1927 doi:10.1007/s00467-025-06656-x.

    PMID: 39862309
  45. 45

    Exploring the experiences of parents of children with Duchenne muscular dystrophy in Turkey: A descriptive phenomenological study.

    Bakir E, Arslanli SE

    Journal of pediatric nursing 2025; (82()):65-74 doi:10.1016/j.pedn.2025.02.015.

    PMID: 40048859
  46. 46

    My A-T pack: a qualitative study of the utility, acceptability, design, and content of a family-designed and owned information pack relevant to the lives of children and young people living with ataxia telangiectasia.

    Khan M, Cassidy E, Parkin T, et al.

    Orphanet journal of rare diseases 2025; (20(1)):397 doi:10.1186/s13023-025-03919-6.

    PMID: 40759969
  47. 47

    Hereditary Hypophosphatemic Rickets with Hypercalciuria-Importance of Further Evaluation when Clinical Suspicion is Strong

    Wettasinghe CA, Kumarasiri IM, Vidushajini M, et al.

    Journal of clinical research in pediatric endocrinology 2026; (18(3)):549-553 doi:10.4274/jcrpe.galenos.2025.2025-1-15.

    PMID: 40820604
  48. 48

    Identification of a Novel Homozygous SLC34A1 Missense Mutation and a Heterozygous SLC34A3 Deletion in an Infant with Nephrocalcinosis, Failure to Thrive, and Hypercalcemia.

    Mura-Escorche G, García-Suarez LC, Lebredo-Álvarez I, et al.

    International journal of molecular sciences 2025; (26(17)) doi:10.3390/ijms26178541.

    PMID: 40943461
  49. 49

    Health-related quality of life in French pediatric patients with X-linked hypophosphatemia: real-world data from the International XLH Registry.

    Linglart A, Amouroux C, Gueorguieva I, et al.

    JBMR plus 2025; (9(10)):ziaf142 doi:10.1093/jbmrpl/ziaf142.

    PMID: 41030383
  50. 50

    Clinical variation in Lowe syndrome: what and how?

    Brewer ED

    Frontiers in cell and developmental biology 2025; (13()):1720452 doi:10.3389/fcell.2025.1720452.

    PMID: 41278199
  51. 51

    Targeting Hypercalciuria in SLC34A1-Related Disorders: Impact of Oral Phosphate Therapy and Novel Genetic Insights in Pediatric Case Series.

    Turan I, Atar M, Eltan M, et al.

    Calcified tissue international 2026; (117(1)):10 doi:10.1007/s00223-025-01462-x.

    PMID: 41543768
  52. 52

    Refractory Rickets: Evaluation and Management.

    Krishnamurthy S

    Indian journal of pediatrics 2026; (93(6)):612-620 doi:10.1007/s12098-026-06032-z.

    PMID: 41741919
  53. 53

    Coping with the challenges of caregiving: A qualitative exploration of the experiences of family caregivers of children with rare diseases in South Africa.

    van Niekerk J, Gush M, Moosa S, Pretorius C

    Journal of genetic counseling 2026; (35(2)):e70205 doi:10.1002/jgc4.70205.

    PMID: 41958204
  54. 54

    Disease trajectories and lived experiences of patients with X-linked hypophosphatemia in Taiwan: a qualitative study.

    Liu SY, Tung YC, Hsu CC, et al.

    JBMR plus 2026; (10(11)):ziag163 doi:10.1093/jbmrpl/ziag163.

    PMID: 42927306